NewLimit

Verified

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Company News NewLimit Team Profile Biotech Startups Series B Route United States News

About NewLimit

NewLimit is tracked on 100Xfounder as a biotech company, founded in 2022, based in San Francisco Bay Area, California, USA, currently mapped to the Series B stage. Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Profile snapshot: Founders linked: NewLimit Team. Funding tracked: $130.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

NewLimit appears in the 100Xfounder startup directory import feed.

Why it Matters

NewLimit is worth tracking because its funding history is already mapped here, including a $130.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and NewLimit Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $130.00MLast Round: Series B Founders Fund, $130M Series B in 2025All Rounds: 1

Series B | Founders Fund, $130M Series B in 2025

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

NewLimit Team

Founder & CEO

Founder Profile LinkedIn

Tech Stack

AWSReactPythonPostgreSQL

Last updated: May 10, 2026

NewLimit research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

Company summary
Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare
Founders covered
NewLimit Team
Market position
Biotech | Series B | San Francisco Bay Area, California, USA
Newsroom signal
No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.
Funding signal
$130.00M

Best next clicks

Company News Hub NewLimit Team United States News Biotech Startups Series B Funding News

Active topics

Startup News Founder Intelligence

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Biotech with comparable market signals.

ROME Therapeutics

ROME Therapeutics Team

View Company Industry Hub

Hoxton Farms

Hoxton Farms Team

View Company Industry Hub

Kernel

Kernel Team

View Company Industry Hub

Synchron

Synchron Team

View Company Industry Hub

Clear Labs

Clear Labs Team

View Company Industry Hub

BioAge Labs

BioAge Labs Team

View Company Industry Hub

Karius

Karius Team

View Company Industry Hub

CAMP4 Therapeutics

CAMP4 Therapeutics Team

View Company Industry Hub

Discover Now

Newsroom and topic pages connected to NewLimit.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Founder profile→United States startup directory→Startups in United States→Biotech hub→Biotech startup list→Series B startup list→Series B newsroom→Biotech startups in United States→Founder directory→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About NewLimit

Common questions people ask about this profile.

What is NewLimit?

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Who founded NewLimit?

NewLimit is associated with NewLimit Team on 100Xfounder.

Where is NewLimit located?

NewLimit is listed in San Francisco Bay Area, California, USA.

What stage is NewLimit in?

NewLimit is currently mapped to Series B. Funding context: Founders Fund, $130M Series B in 2025

What is the latest funding round of NewLimit?

NewLimit's latest tracked round is Series B Founders Fund, $130M Series B in 2025. Total tracked rounds: 1.

Is NewLimit hiring now?

NewLimit hiring status: Open Roles.

What technologies does NewLimit use?

NewLimit is associated with AWS, React, Python, and PostgreSQL.

Is NewLimit verified on 100Xfounder?

Yes. NewLimit is currently marked verified on 100Xfounder as of May 10, 2026.

How can users connect with NewLimit founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.